The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results of REGOMA: A randomized, multicenter, controlled open-label phase II clinical trial evaluating regorafenib in relapsed glioblastoma (GBM) patients (PTS).
 
Giuseppe Lombardi
No Relationships to Disclose
 
Gian Luca De Salvo
Travel, Accommodations, Expenses - Bayer
 
Roberta Ruda
No Relationships to Disclose
 
Enrico Franceschi
No Relationships to Disclose
 
Marica Eoli
No Relationships to Disclose
 
Marina Faedi
No Relationships to Disclose
 
Andrea Pace
No Relationships to Disclose
 
Ivan Lolli
No Relationships to Disclose
 
Simona Rizzato
No Relationships to Disclose
 
Domenico Germano
No Relationships to Disclose
 
Francesco Pasqualetti
No Relationships to Disclose
 
Miriam Farina
No Relationships to Disclose
 
Giovanna Magni
No Relationships to Disclose
 
Luisa Bellu
No Relationships to Disclose
 
Ardi Pambuku
No Relationships to Disclose
 
Eleonora Bergo
No Relationships to Disclose
 
Stefano Indraccolo
No Relationships to Disclose
 
Marina Paola Gardiman
No Relationships to Disclose
 
Riccardo Soffietti
Consulting or Advisory Role - Celldex; Roche/Genentech
 
Vittorina Zagonel
No Relationships to Disclose